SkinHealth Systems Inc. (SKIN)
NASDAQ: SKIN · Real-Time Price · USD
0.6546
+0.0046 (0.71%)
At close: May 12, 2026, 4:00 PM EDT
0.6546
0.00 (0.00%)
After-hours: May 12, 2026, 4:01 PM EDT
SkinHealth Systems Stock Forecast
Stock Price Forecast
The 4 analysts that cover SkinHealth Systems stock have a consensus rating of "Buy" and an average price target of $1.90, which forecasts a 190.25% increase in the stock price over the next year. The lowest target is $1.00 and the highest is $3.50.
Price Target: $1.90 (+190.25%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for SkinHealth Systems stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.5 → $1 | Hold | Maintains | $1.5 → $1 | +52.77% | May 1, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $1.65 → $1.5 | Hold | Maintains | $1.65 → $1.5 | +129.15% | Mar 16, 2026 |
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $1.5 | Hold | Maintains | $1.5 | +129.15% | Mar 13, 2026 |
| TD Cowen | TD Cowen | Hold Maintains $1.5 → $1.65 | Hold | Maintains | $1.5 → $1.65 | +152.06% | Jan 21, 2026 |
| Jefferies | Jefferies | Hold Initiates $1.6 | Hold | Initiates | $1.6 | +144.42% | Jan 14, 2026 |
Financial Forecast
Revenue This Year
303.45M
from 300.79M
Increased by 0.88%
Revenue Next Year
317.42M
from 303.45M
Increased by 4.60%
EPS This Year
-0.15
from -0.16
EPS Next Year
-0.13
from -0.15
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2032 |
|---|---|---|---|---|
| High | 320.4M | 340.7M | ||
| Avg | 303.5M | 317.4M | ||
| Low | 285.2M | 296.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2032 |
|---|---|---|---|---|
| High | 6.5% | 12.3% | ||
| Avg | 0.9% | 4.6% | ||
| Low | -5.2% | -2.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.07 | 0.04 | |
| Avg | -0.15 | -0.13 | |
| Low | -0.30 | -0.21 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.